<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100966035</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22040</journal-id>
<journal-id journal-id-type="nlm-ta">Trends Mol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Trends Mol Med</journal-id>
<journal-title-group>
<journal-title>Trends in molecular medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1471-4914</issn>
<issn pub-type="epub">1471-499X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27085812</article-id>
<article-id pub-id-type="pmc">4853753</article-id>
<article-id pub-id-type="doi">10.1016/j.molmed.2016.03.006</article-id>
<article-id pub-id-type="manuscript">NIHMS773075</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cerebellum Development and Tumorigenesis: a p53-centric Perspective</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Barthelery</surname>
<given-names>Nicolas J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manfredi</surname>
<given-names>James J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Oncological Sciences and The Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding author: <email>james.manfredi@mssm.edu</email> (J.J. Manfredi)</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2017</year>
</pub-date>
<volume>22</volume>
<issue>5</issue>
<fpage>404</fpage>
<lpage>413</lpage>
<!--elocation-id from pubmed: 10.1016/j.molmed.2016.03.006-->
<abstract>
<p id="P2">The p53 protein has been extensively studied for its role in suppressing tumorigenesis, in part through surveillance and maintenance of genomic stability. p53 has been associated with the induction of a variety of cellular outcomes including cell cycle arrest, senescence, and apoptosis. This occurs primarily, but not exclusively, through transcriptional activation of specific target genes. By contrast, the participation of p53 in normal developmental processes has been largely understudied. This review focuses on possible functions of p53 in cerebellar development. It can be argued that a better understanding of such mechanisms will provide needed insight into the genesis of certain embryonic cancers including medulloblastomas, and thus lead to more effective therapies.</p>
</abstract>
<kwd-group>
<kwd>p53</kwd>
<kwd>Sonic Hedgehog pathway</kwd>
<kwd>cerebellum development</kwd>
<kwd>medulloblastomas</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>